A000520 logo

Samil Pharmaceutical Co.,Ltd Stock Price

KOSE:A000520 Community·₩150.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A000520 Share Price Performance

₩0
-10070.00 (-100.00%)
₩0
-10070.00 (-100.00%)
Price ₩0

A000520 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Mediocre balance sheet and slightly overvalued.

1 Risk
0 Rewards

Samil Pharmaceutical Co.,Ltd Key Details

₩210.5b

Revenue

₩134.8b

Cost of Revenue

₩75.7b

Gross Profit

₩112.2b

Other Expenses

-₩36.4b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-1.70k
35.98%
-17.30%
127.5%
View Full Analysis

About A000520

Founded
1947
Employees
583
CEO
Seung Bum Huh
WebsiteView website
www.samil-pharm.com

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of pharmaceuticals in South Korea. It offers general medicines, including Tiersil Once, EYE2O mini eye drops, and Optagent ophthalmic drops; medical devices; secret spotpatch quasi-drugs, and roll away products. The company also provides specialty medicines, such as Hycell solutions; Curelen, Ocufridine, Ocumetholone, Ocucyclo, Ocuhomapine, Ocucarpine, Allerfen, Optanac, Forus, Eymox, Cifex, and Ocuracin ophthalmic drops; and Herpecid, Forus, and Ocurasin ophthalmic ointments. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Seoul, South Korea.

Recent A000520 News & Updates

Analysis Article Jan 28

Samil Pharmaceutical Co.,Ltd's (KRX:000520) Shares May Have Run Too Fast Too Soon

It's not a stretch to say that Samil Pharmaceutical Co.,Ltd's ( KRX:000520 ) price-to-sales (or "P/S") ratio of 1x...

Recent updates

No updates